Texas InstrumentsTPS76933DBVRLinear Regulators

LDO Regulator Pos 3.3V 0.1A 5-Pin SOT-23 T/R

This LDO TPS76933DBVR linear regulator from Texas Instruments is used to manipulate the voltage level of your circuit. Its typical dropout voltage at current is 0.048@50mA|0.098@100mA V. It has an overall accuracy of ±3 %. This device has a maximum power dissipation of 555 mW. This voltage regulation device's single output can produce a current up to 0.1 A. By only needing an input voltage of 2.7 V with a maximum of 10 V, this is the best way to control the power in your circuit. With a fixed output that has a voltage of 3.3 V, this is power management at its best. At a load regulation of 12mV(Typ) and line regulation of 0.04%/V(Typ) your circuit is capable of maintaining a constant voltage level at your output. Its maximum power dissipation is 555 mW. In order to guarantee safe delivery and allow for quick mounting of this component after delivery, it will be enclosed in tape and reel packaging during shipment. Its polarity is positive. This voltage regulation device has a minimum operating temperature of -40 °C and a maximum of 125 °C. The maximum dropout voltage is 0.1@50mA|0.2@100mA V.

76 parts: Ships tomorrow

    Total$0.94Price for 1

    • Service Fee  $7.00

      Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2522+
      Manufacturer Lead Time:
      6 weeks
      Minimum Of :
      1
      Maximum Of:
      76
      Country Of origin:
      Philippines
         
      • Price: $0.9370
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2522+
      Manufacturer Lead Time:
      6 weeks
      Country Of origin:
      Philippines
      • In Stock: 76 parts
      • Price: $0.9370

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.